MEDSIR, a leading international company in oncology research, has announced the results of the PHERGuide study during the 2025 San Antonio Breast Cancer Symposium (SABCS). This research, presented as ...
Since its peak in 1991, the cancer death rate has dropped 34%, averting an estimated 4.5 million deaths due, in part, to earlier detection of the most common types of cancer. Screening tests are ...
The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...
ENGLEWOOD, N.J.--(BUSINESS WIRE)--SpotitEarly, a biotech startup focused on transforming cancer screening by harnessing the power of artificial intelligence and canines to analyze volatile organic ...
Stockhead on MSN
Biocurious: AI becomes the hidden helping hand in clinical trial design and analysis
Drug developers increasingly are harnessing AI to optimise clinical trial patient selection and to interpret results to ...
Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved outcomes in each. 1-4 But one complication among them remains incurable: ...
September is Blood Cancer Awareness Month. Early detection and clinical trials improve survival for leukemia, lymphoma, and myeloma. Learn more at cancercarescri.com. Police chiefs call for total ban ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback